BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

FRA:BX2 (USA)  
€ 2.37 (-1.62%) Apr 30
At Loss
Market Cap:
€ 71.91M ($ 76.63M)
Enterprise V:
€ 105.66M ($ 112.59M)
Volume:
-
Avg Vol (2M):
4.37K
Also Trade In:

My Checklist

Inactive
Item Name
Rating
Action

Fair Value Votes

Date Voted
Fair Value
Price on Date Voted
% Change Since Voted
% Change Relative to SP500
10/Page
Total 0

My Votes

My Vote : €